Viewing Study NCT00724360


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-27 @ 11:19 PM
Study NCT ID: NCT00724360
Status: TERMINATED
Last Update Posted: 2013-10-07
First Post: 2008-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab for HER2 Positive Relapsed/Refractory B-Acute Lymphoblastic Leukemia (B-ALL)
Sponsor: Nantes University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module